Kızılay Biomedical

Kızılay Biomedical

Kızılay Biomedical

Turkish Red Crescent, assigned to meet the blood need of Turkey, fullfills 90% of Turkey's blood demand and imports 3 million blood bags annually for safe blood supply. Kızılay Biomedical will make an investment to respond to the blood bag needs of Kızılay Blood Services in the first phase. As a result of this investment, 3 million sets will be produced annually on 21.000 m² in Çatalca with 237 personnel. In the second phase, it is aimed to increase the capacity and produce for export markets.


What Does Kızılay Biomedical Do?

- Develops bag systems to best store blood components

- Builds blood-based business models with the Red Crescent or Red Cross around the world

- Executes/supports blood-based R&D studies              

- Supports local production by preventing imports

- Reaches wide export markets

- Runs to a common goal with all potential stakeholders in the medical sector

Use of Cookies
For more detailed information about the purposes of processing your personal data by Kızılay Yatırım, we recommend you to read the Cookie Policy Clarification Text